CG
PTLA

Cutler Group’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Cutler Group’s Portfolio PTLA Stock Details PTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-1,500
Closed -$10K – 5168
2020
Q1 		$10K Sell
1,500
-22,100
-94% -$276K ﹤0.01% 2744
2019
Q4 		$563K Buy
23,600
+8,100
+52% +$223K 0.03% 406
2019
Q3 		$415K Buy
15,500
+3,600
+30% +$101K 0.04% 408
2019
Q2 		$322K Buy
11,900
+3,000
+34% +$94.1K 0.03% 498
2019
Q1 		$308K Buy
8,900
+8,280
+1,335% +$239K 0.03% 480
2018
Q4 		$12K Sell
620
-17,108
-97% -$352K ﹤0.01% 2451
2018
Q3 		$472K Sell
17,728
-100
-0.6% -$3.27K 0.03% 483
2018
Q2 		$673K Sell
17,828
-12,909
-42% -$494K 0.05% 355
2018
Q1 		$1M Buy
30,737
+3,224
+12% +$141K 0.09% 227
2017
Q4 		$1.34M Sell
27,513
-5,246
-16% -$265K 0.05% 257
2017
Q3 		$1.77M Buy
32,759
+11,921
+57% +$700K 0.07% 222
2017
Q2 		$1.17M Sell
20,838
-2,315
-10% -$92.7K 0.04% 366
2017
Q1 		$907K Buy
23,153
+2,349
+11% +$74.8K 0.04% 425
2016
Q4 		$466K Buy
20,804
+15,303
+278% +$299K 0.02% 732
2016
Q3 		$124K Sell
5,501
-134
-2% -$3.15K 0.01% 1635
2016
Q2 		$132K Buy
5,635
+734
+15% +$18.1K 0.01% 1455
2016
Q1 		$99K Buy
4,901
+3,957
+419% +$126K 0.01% 1635
2015
Q4 		$48K Buy
+944
New +$45.8K ﹤0.01% 2510

Other funds holding PTLA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
OP
Omni Partners London, United Kingdom $2.03B AUM 126.33% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
VI
Versor Investments New York $40.8M AUM 93.59% 1-Year Est. Return

Cutler Group's PTLA Position: Q2 2020 in Review

Cutler Group sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q2 2020, closing a stake of 1,500 shares — an estimated $10K sold.

Cutler Group first reported a position in PTLA in Q4 2015 and held it in 18 quarters. The position peaked at $1.77M in Q3 2017. 162 funds tracked by Wall St. Rank hold PTLA as of Q2 2020.

  • Cutler Group reported no remaining Portola Pharmaceuticals, Inc. position as of Q2 2020 after selling out during the quarter.
  • Cutler Group sold 1,500 Portola Pharmaceuticals, Inc. shares in Q2 2020, an estimated $10K.
  • Cutler Group first reported a position in Portola Pharmaceuticals, Inc. in Q4 2015 and held it in 18 quarters.
  • Cutler Group's Portola Pharmaceuticals, Inc. position peaked at $1.77M in Q3 2017.
  • 162 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q2 2020.

Based on Cutler Group's 13F filing for Q2 2020, filed 22 Jul 2020.